Trastuzumab deruxtecan (T-Dxd DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH
dc.conference.date | SEP 16-21, 2021 | |
dc.conference.title | Congress of the European-Society-for-Medical-Oncology (ESMO) | |
dc.contributor.author | Vaz Batista, M. | |
dc.contributor.author | Perez-Garcia, J. M. | |
dc.contributor.author | Llombart Cussac, A. | |
dc.contributor.author | Cortez, P. | |
dc.contributor.author | Ruiz Borrego, M. | |
dc.contributor.author | De la Haba, J. | |
dc.contributor.author | Cejalvo, J. M. | |
dc.contributor.author | Racca, F. | |
dc.contributor.author | Servitja, S. | |
dc.contributor.author | Blanch, S. | |
dc.contributor.author | Lema, L. | |
dc.contributor.author | Galan Garmaje, M. | |
dc.contributor.author | Fernandez-Abad, M. | |
dc.contributor.author | Fernandez, A. | |
dc.contributor.author | Iranzo, V. | |
dc.contributor.author | Gonzalez-Santiago, S. | |
dc.contributor.author | Gion, M. | |
dc.contributor.author | Nave, M. | |
dc.contributor.author | Cortes, J. | |
dc.contributor.author | Braga, S. | |
dc.contributor.authoraffiliation | [Vaz Batista, M.] Hosp Prof Doutor Fernando Fonseca EPE, Med Oncol Dept, Lisbon, Portugal | |
dc.contributor.authoraffiliation | [Braga, S.] Hosp Prof Doutor Fernando Fonseca EPE, Med Oncol Dept, Lisbon, Portugal | |
dc.contributor.authoraffiliation | [Perez-Garcia, J. M.] Int Breast Canc Ctr IBCC, Med Oncol Dept, Quiron Grp, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Cortez, P.] Int Breast Canc Ctr IBCC, Med Oncol Dept, Quiron Grp, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Llombart Cussac, A.] Hosp Arnau Vilanova, Med Oncol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Ruiz Borrego, M.] Hosp Univ Virgen Rocio, Med Oncol Dept, Seville, Spain | |
dc.contributor.authoraffiliation | [De la Haba, J.] Hosp Univ Reina SofIa, Oncol Dept, Cordoba, Spain | |
dc.contributor.authoraffiliation | [Cejalvo, J. M.] Univ Valencia, Hosp Clin, INCLIVA Inst Invest Sanit, Med Oncol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Racca, F.] IOB Inst Oncol, Med Oncol Dept, Quiron Grp, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Servitja, S.] Hosp Mar, Med Oncol Dept, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Blanch, S.] Fdn Inst Valenciano Oncol, Med Oncol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Lema, L.] Hosp 12 Octubre, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Galan Garmaje, M.] Hosp Univ Son Llatzer, Med Oncol Dept, Palma De Mallorca, Spain | |
dc.contributor.authoraffiliation | [Fernandez-Abad, M.] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Fernandez, A.] Inst Catala Oncol, Med Oncol Dept, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Iranzo, V.] Univ Valencia, Hosp Gen, Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Gonzalez-Santiago, S.] Hosp Univ San Pedro Alcantara, Med Oncol Dept, Caceres, Spain | |
dc.contributor.authoraffiliation | [Gion, M.] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Nave, M.] Hosp Luz, Med Oncol Dept, Lisbon, Portugal | |
dc.contributor.authoraffiliation | [Cortes, J.] VHIO Valle Hebron Inst Oncol, Oncol Dept, Barcelona, Spain | |
dc.contributor.funder | AZ/Daiichi Sankyo | |
dc.date.accessioned | 2025-01-07T13:53:25Z | |
dc.date.available | 2025-01-07T13:53:25Z | |
dc.date.issued | 2021-09-21 | |
dc.identifier.doi | 10.1016/j.annonc.2021.08.613 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.annonc.2021.08.613 | |
dc.identifier.uri | https://hdl.handle.net/10668/25937 | |
dc.identifier.wosID | 700527700309 | |
dc.issue.number | 5 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Reina Sofía | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.page.number | S509-S510 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | Trastuzumab deruxtecan (T-Dxd DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 32 | |
dc.wostype | Meeting Abstract |